{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T20:25:06Z","timestamp":1791318306312,"version":"4.3.1"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T00:00:00Z","timestamp":1745193600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The NHC Key Lab of Drug Addiction Medicine (Kunming Medical University) Open Projects Fund","award":["KN202411 and KN202420"],"award-info":[{"award-number":["KN202411 and KN202420"]}]},{"name":"The NHC Key Lab of Drug Addiction Medicine (Kunming Medical University) Open Projects Fund","award":["KN202411 and KN202420"],"award-info":[{"award-number":["KN202411 and KN202420"]}]},{"name":"Kunming Medical University Talent Introduction Research Project","award":["K132310511 and K132310529"],"award-info":[{"award-number":["K132310511 and K132310529"]}]},{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["82260654"],"award-info":[{"award-number":["82260654"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100005273","name":"Natural Science Foundation of Yunnan Province","doi-asserted-by":"publisher","award":["202303AC100021"],"award-info":[{"award-number":["202303AC100021"]}],"id":[{"id":"10.13039\/501100005273","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-025-97523-0","type":"journal-article","created":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T09:03:39Z","timestamp":1745226219000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Uncovering mechanism of hepatotoxicity diseases caused by tetrahydrocannabinol based on novel network toxicology and experimental verification"],"prefix":"10.1038","volume":"15","author":[{"given":"Tiantian","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruilin","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genmeng","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuanyu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengqing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiantian","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengjie","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linlin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shijun","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,21]]},"reference":[{"key":"97523_CR1","first-page":"495","volume":"109","author":"F Grotenhermen","year":"2012","unstructured":"Grotenhermen, F. & Muller-Vahl, K. The therapeutic potential of cannabis and cannabinoids. Dtsch. Arztebl Int. 109, 495\u2013501 (2012).","journal-title":"Dtsch. Arztebl Int."},{"key":"97523_CR2","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1513\/AnnalsATS.201212-127FR","volume":"10","author":"DP Tashkin","year":"2013","unstructured":"Tashkin, D. P. Effects of marijuana smoking on the lung. Ann. Am. Thorac. Soc. 10, 239\u2013247 (2013).","journal-title":"Ann. Am. Thorac. Soc."},{"key":"97523_CR3","doi-asserted-by":"publisher","first-page":"187","DOI":"10.7326\/M17-1548","volume":"168","author":"D Ravi","year":"2018","unstructured":"Ravi, D., Ghasemiesfe, M., Korenstein, D., Cascino, T. & Keyhani, S. Associations between marijuana use and cardiovascular risk factors and outcomes: A systematic review. Ann. Intern. Med. 168, 187\u2013194 (2018).","journal-title":"Ann. Intern. Med."},{"key":"97523_CR4","doi-asserted-by":"publisher","first-page":"292","DOI":"10.1001\/jamapsychiatry.2015.3278","volume":"73","author":"ND Volkow","year":"2016","unstructured":"Volkow, N. D. et al. Effects of cannabis use on human behavior, including cognition, motivation, and psychosis: A review. JAMA Psychiatry. 73, 292\u2013297 (2016).","journal-title":"JAMA Psychiatry"},{"key":"97523_CR5","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1016\/j.drugalcdep.2010.11.004","volume":"115","author":"C Lopez-Quintero","year":"2011","unstructured":"Lopez-Quintero, C. et al. Probability and predictors of transition from first use to dependence on nicotine, alcohol, cannabis, and cocaine: results of the National epidemiologic survey on alcohol and related conditions (NESARC). Drug Alcohol Depend. 115, 120\u2013130 (2011).","journal-title":"Drug Alcohol Depend."},{"key":"97523_CR6","doi-asserted-by":"publisher","first-page":"1411","DOI":"10.1111\/j.1476-5381.2010.01176.x","volume":"163","author":"LA Parker","year":"2011","unstructured":"Parker, L. A., Rock, E. M. & Limebeer, C. L. Regulation of nausea and vomiting by cannabinoids. Br. J. Pharmacol. 163, 1411\u20131422 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"97523_CR7","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1111\/nmo.12931","volume":"28","author":"C Hasenoehrl","year":"2016","unstructured":"Hasenoehrl, C., Taschler, U., Storr, M. & Schicho, R. The Gastrointestinal tract - a central organ of cannabinoid signaling in health and disease. Neurogastroenterol Motil. 28, 1765\u20131780 (2016).","journal-title":"Neurogastroenterol Motil."},{"key":"97523_CR8","doi-asserted-by":"publisher","first-page":"1770","DOI":"10.1002\/cbdv.200790152","volume":"4","author":"MA Huestis","year":"2007","unstructured":"Huestis, M. A. Human cannabinoid pharmacokinetics. Chem. Biodivers. 4, 1770\u20131804 (2007).","journal-title":"Chem. Biodivers."},{"key":"97523_CR9","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1097\/MEG.0000000000000779","volume":"29","author":"H Goyal","year":"2017","unstructured":"Goyal, H., Singla, U., Gupta, U. & May, E. Role of cannabis in digestive disorders. Eur. J. Gastroenterol. Hepatol. 29, 135\u2013143 (2017).","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"97523_CR10","doi-asserted-by":"crossref","unstructured":"Fearby, N., Penman, S. & Thanos, P. Effects of Delta9-Tetrahydrocannibinol (THC) on obesity at different stages of life: A literature review. Int. J. Environ. Res. Public. Health 19, 3174 (2022).","DOI":"10.3390\/ijerph19063174"},{"key":"97523_CR11","doi-asserted-by":"crossref","unstructured":"Eitan, A., Gover, O., Sulimani, L., Meiri, D. & Schwartz, B. The effect of orally administered Delta9-Tetrahydrocannabinol (THC) and Cannabidiol (CBD) on obesity parameters in mice. Int. J. Mol. Sci. 24,13797 (2023).","DOI":"10.3390\/ijms241813797"},{"key":"97523_CR12","first-page":"134","volume":"33","author":"A Perisetti","year":"2020","unstructured":"Perisetti, A., Rimu, A. H., Khan, S. A., Bansal, P. & Goyal, H. Role of cannabis in inflammatory bowel diseases. Ann. Gastroenterol. 33, 134\u2013144 (2020).","journal-title":"Ann. Gastroenterol."},{"key":"97523_CR13","doi-asserted-by":"crossref","unstructured":"Carvalho, A. C. A. et al. Cannabis and canabidinoids on the inflammatory bowel diseases: going beyond misuse. Int. J. Mol. Sci. 21, 2940 (2020).","DOI":"10.3390\/ijms21082940"},{"key":"97523_CR14","doi-asserted-by":"publisher","first-page":"301","DOI":"10.18433\/jpps31242","volume":"23","author":"L Cohen","year":"2020","unstructured":"Cohen, L. & Neuman, M. G. Cannabis and the Gastrointestinal tract. J. Pharm. Pharm. Sci. 23, 301\u2013313 (2020).","journal-title":"J. Pharm. Pharm. Sci."},{"key":"97523_CR15","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1053\/j.gastro.2020.03.087","volume":"159","author":"J Gotfried","year":"2020","unstructured":"Gotfried, J., Naftali, T. & Schey, R. Role of cannabis and its derivatives in Gastrointestinal and hepatic disease. Gastroenterology 159, 62\u201380 (2020).","journal-title":"Gastroenterology"},{"key":"97523_CR16","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1016\/j.jhep.2013.03.032","volume":"59","author":"A Mallat","year":"2013","unstructured":"Mallat, A., Teixeira-Clerc, F. & Lotersztajn, S. Cannabinoid signaling and liver therapeutics. J. Hepatol. 59, 891\u2013896 (2013).","journal-title":"J. Hepatol."},{"key":"97523_CR17","doi-asserted-by":"crossref","unstructured":"McCain, K. R. et al. Impaired driving associated with the synthetic cannabinoid 5f-Adb. J. Forensic Sci. Criminol. 6,1-4 (2018).","DOI":"10.15744\/2348-9804.6.105"},{"key":"97523_CR18","first-page":"1","volume":"21","author":"R Solimini","year":"2017","unstructured":"Solimini, R. et al. Hepatotoxicity associated to synthetic cannabinoids use. Eur. Rev. Med. Pharmacol. Sci. 21, 1\u20136 (2017).","journal-title":"Eur. Rev. Med. Pharmacol. Sci."},{"key":"97523_CR19","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.cbi.2018.08.009","volume":"294","author":"L Prester","year":"2018","unstructured":"Prester, L. et al. Effects of Delta(9)-tetrahydrocannabinol on irinotecan-induced clinical effects in rats. Chem. Biol. Interact. 294, 128\u2013134 (2018).","journal-title":"Chem. Biol. Interact."},{"key":"97523_CR20","doi-asserted-by":"crossref","unstructured":"Lucic Vrdoljak, A. et al., Irinotecan and Delta(8)-Tetrahydrocannabinol Interactions in Rat Liver: A Preliminary Evaluation Using Biochemical and Genotoxicity Markers. Molecules 23, (2018).","DOI":"10.3390\/molecules23061332"},{"key":"97523_CR21","doi-asserted-by":"publisher","first-page":"167904","DOI":"10.1016\/j.scitotenv.2023.167904","volume":"905","author":"S Huang","year":"2023","unstructured":"Huang, S. Efficient analysis of toxicity and mechanisms of environmental pollutants with network toxicology and molecular Docking strategy: acetyl tributyl citrate as an example. Sci. Total Environ. 905, 167904 (2023).","journal-title":"Sci. Total Environ."},{"key":"97523_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.jep.2012.09.051","volume":"145","author":"W Tao","year":"2013","unstructured":"Tao, W. et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal radix curcumae formula for application to cardiovascular disease. J. Ethnopharmacol. 145, 1\u201310 (2013).","journal-title":"J. Ethnopharmacol."},{"key":"97523_CR23","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1186\/s13020-017-0145-x","volume":"12","author":"Y Zhang","year":"2017","unstructured":"Zhang, Y. et al. A network pharmacology-based strategy Deciphers the underlying molecular mechanisms of Qixuehe capsule in the treatment of menstrual disorders. Chin. Med. 12, 23 (2017).","journal-title":"Chin. Med."},{"key":"97523_CR24","doi-asserted-by":"crossref","unstructured":"Zhang, S. et al. Systematic analysis of the multiple bioactivities of green tea through a network Pharmacology approach. Evid. Based Complement. Alternat Med. 2014, 512081 (2014).","DOI":"10.1155\/2014\/512081"},{"key":"97523_CR25","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1016\/bs.pmch.2021.01.004","volume":"60","author":"F Stanzione","year":"2021","unstructured":"Stanzione, F., Giangreco, I. & Cole, J. C. Use of molecular Docking computational tools in drug discovery. Prog Med. Chem. 60, 273\u2013343 (2021).","journal-title":"Prog Med. Chem."},{"key":"97523_CR26","doi-asserted-by":"crossref","unstructured":"Pinzi, L. & Rastelli, G. Molecular docking: shifting paradigms in drug discovery. Int. J. Mol. Sci. 20, 4331 (2019).","DOI":"10.3390\/ijms20184331"},{"key":"97523_CR27","doi-asserted-by":"publisher","first-page":"D1074","DOI":"10.1093\/nar\/gkx1037","volume":"46","author":"DS Wishart","year":"2018","unstructured":"Wishart, D. S. et al. DrugBank 5.0: a major update to the drugbank database for 2018. Nucleic Acids Res. 46, D1074\u2013D1082 (2018).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR28","doi-asserted-by":"publisher","first-page":"W357","DOI":"10.1093\/nar\/gkz382","volume":"47","author":"A Daina","year":"2019","unstructured":"Daina, A., Michielin, O. & Zoete, V. SwissTargetPrediction: updated data and new features for efficient prediction of protein targets of small molecules. Nucleic Acids Res. 47, W357\u2013W364 (2019).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR29","first-page":"D845","volume":"48","author":"J Pinero","year":"2020","unstructured":"Pinero, J. et al. The disgenet knowledge platform for disease genomics: 2019 update. Nucleic Acids Res. 48, D845\u2013D855 (2020).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR30","doi-asserted-by":"crossref","unstructured":"Safran, M. et al. GeneCards Version 3: the human gene integrator. Database (Oxford) baq020 (2010). (2010).","DOI":"10.1093\/database\/baq020"},{"key":"97523_CR31","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1093\/nar\/30.1.412","volume":"30","author":"X Chen","year":"2002","unstructured":"Chen, X., Ji, Z. L. & Chen, Y. Z. TTD: therapeutic target database. Nucleic Acids Res. 30, 412\u2013415 (2002).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR32","doi-asserted-by":"publisher","first-page":"D394","DOI":"10.1093\/nar\/gkaa1106","volume":"49","author":"H Mi","year":"2021","unstructured":"Mi, H. et al. PANTHER version 16: a revised family classification, tree-based classification tool, enhancer regions and extensive API. Nucleic Acids Res. 49, D394\u2013D403 (2021).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR33","doi-asserted-by":"publisher","first-page":"D607","DOI":"10.1093\/nar\/gky1131","volume":"47","author":"D Szklarczyk","year":"2019","unstructured":"Szklarczyk, D. et al. STRING v11: protein-protein association networks with increased coverage, supporting functional discovery in genome-wide experimental datasets. Nucleic Acids Res. 47, D607\u2013D613 (2019).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR34","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1093\/nar\/28.1.27","volume":"28","author":"M Kanehisa","year":"2000","unstructured":"Kanehisa, M. & Goto, S. KEGG: Kyoto encyclopedia of genes and genomes. Nucleic Acids Res. 28, 27\u201330 (2000).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR35","doi-asserted-by":"publisher","first-page":"1947","DOI":"10.1002\/pro.3715","volume":"28","author":"M Kanehisa","year":"2019","unstructured":"Kanehisa, M. Toward Understanding the origin and evolution of cellular organisms. Protein Sci. 28, 1947\u20131951 (2019).","journal-title":"Protein Sci."},{"key":"97523_CR36","doi-asserted-by":"publisher","first-page":"D587","DOI":"10.1093\/nar\/gkac963","volume":"51","author":"M Kanehisa","year":"2023","unstructured":"Kanehisa, M., Furumichi, M., Sato, Y., Kawashima, M. & Ishiguro-Watanabe, M. KEGG for taxonomy-based analysis of pathways and genomes. Nucleic Acids Res. 51, D587\u2013D592 (2023).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR37","doi-asserted-by":"publisher","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis Jr","year":"2003","unstructured":"Dennis, G. Jr Database for annotation, visualization, and integrated discovery. Genome Biol. 4, P3 (2003).","journal-title":"Genome Biol."},{"key":"97523_CR38","doi-asserted-by":"publisher","first-page":"D1202","DOI":"10.1093\/nar\/gkv951","volume":"44","author":"S Kim","year":"2016","unstructured":"Kim, S. et al. PubChem substance and compound databases. Nucleic Acids Res. 44, D1202\u20131213 (2016).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR39","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1758-2946-3-33","volume":"3","author":"NM O\u2019Boyle","year":"2011","unstructured":"O\u2019Boyle, N. M. et al. Open babel: an open chemical toolbox. J. Cheminform. 3, 33 (2011).","journal-title":"J. Cheminform"},{"key":"97523_CR40","doi-asserted-by":"publisher","first-page":"W478","DOI":"10.1093\/nar\/gku377","volume":"42","author":"CC Huang","year":"2014","unstructured":"Huang, C. C., Meng, E. C., Morris, J. H., Pettersen, E. F. & Ferrin, T. E. Enhancing UCSF chimera through web services. Nucleic Acids Res. 42, W478\u2013484 (2014).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR41","doi-asserted-by":"publisher","first-page":"D523","DOI":"10.1093\/nar\/gkac1052","volume":"51","author":"UniProt C","year":"2023","unstructured":"UniProt C. UniProt: the universal protein knowledgebase in 2023. Nucleic Acids Res. 51, D523\u2013D531 (2023).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR42","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman, H. M. et al. The protein data bank. Nucleic Acids Res. 28, 235\u2013242 (2000).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR43","doi-asserted-by":"publisher","first-page":"W270","DOI":"10.1093\/nar\/gkr366","volume":"39","author":"A Grosdidier","year":"2011","unstructured":"Grosdidier, A., Zoete, V. & Michielin, O. SwissDock, a protein-small molecule Docking web service based on EADock DSS. Nucleic Acids Res. 39, W270\u2013277 (2011).","journal-title":"Nucleic Acids Res."},{"key":"97523_CR44","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1124\/dmd.121.000442","volume":"49","author":"S Nasrin","year":"2021","unstructured":"Nasrin, S., Watson, C. J. W., Perez-Paramo, Y. X. & Lazarus, P. Cannabinoid metabolites as inhibitors of major hepatic CYP450 enzymes, with implications for Cannabis-Drug interactions. Drug Metab. Dispos. 49, 1070\u20131080 (2021).","journal-title":"Drug Metab. Dispos."},{"key":"97523_CR45","doi-asserted-by":"publisher","first-page":"e252","DOI":"10.2196\/jmir.5802","volume":"18","author":"Z Zhang","year":"2016","unstructured":"Zhang, Z., Zheng, X., Zeng, D. D. & Leischow, S. J. Tracking dabbing using search query surveillance: A case study in the united States. J. Med. Internet Res. 18, e252 (2016).","journal-title":"J. Med. Internet Res."},{"key":"97523_CR46","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1016\/j.amjms.2021.07.005","volume":"362","author":"XP Bai","year":"2021","unstructured":"Bai, X. P., Fan, Y. M., Zhang, L., Yang, G. H. & Li, X. Influence of liver cirrhosis on blood glucose, insulin sensitivity and islet function in mice. Am. J. Med. Sci. 362, 403\u2013417 (2021).","journal-title":"Am. J. Med. Sci."},{"key":"97523_CR47","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.taap.2016.12.010","volume":"316","author":"W Zhang","year":"2017","unstructured":"Zhang, W. et al. Di-(2-ethylhexyl) phthalate could disrupt the insulin signaling pathway in liver of SD rats and L02 cells via PPARgamma. Toxicol. Appl. Pharmacol. 316, 17\u201326 (2017).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"97523_CR48","doi-asserted-by":"crossref","unstructured":"Jiang, H. et al. Hepatoprotective Effect of Medicine Food Homology Flower Saffron against CCl(4)-Induced Liver Fibrosis in Mice via the Akt\/HIF-1alpha\/VEGF Signaling Pathway. Molecules 28, (2023).","DOI":"10.3390\/molecules28217238"},{"key":"97523_CR49","doi-asserted-by":"publisher","first-page":"e2308711","DOI":"10.1002\/advs.202308711","volume":"11","author":"F Chen","year":"2024","unstructured":"Chen, F. et al. VEGF-FGF signaling activates quiescent CD63(+) liver stem cells to proliferate and differentiate. Adv. Sci. (Weinh). 11, e2308711 (2024).","journal-title":"Adv. Sci. (Weinh)"},{"key":"97523_CR50","doi-asserted-by":"publisher","first-page":"117516","DOI":"10.1016\/j.jep.2023.117516","volume":"321","author":"T Lan","year":"2024","unstructured":"Lan, T. et al. Tianhuang formula ameliorates liver fibrosis by inhibiting CCL2-CCR2 axis and MAPK\/NF-kappaB signaling pathway. J. Ethnopharmacol. 321, 117516 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"97523_CR51","doi-asserted-by":"publisher","first-page":"173982","DOI":"10.1016\/j.ejphar.2021.173982","volume":"898","author":"S Cai","year":"2021","unstructured":"Cai, S. et al. Carvacrol alleviates liver fibrosis by inhibiting TRPM7 and modulating the MAPK signaling pathway. Eur. J. Pharmacol. 898, 173982 (2021).","journal-title":"Eur. J. Pharmacol."},{"key":"97523_CR52","doi-asserted-by":"crossref","unstructured":"Ezhilarasan, D. Relaxin in hepatic fibrosis: What is known and where to head? Biochimie 187, 144\u2013151 (2021).","DOI":"10.1016\/j.biochi.2021.06.001"},{"key":"97523_CR53","doi-asserted-by":"publisher","first-page":"117975","DOI":"10.1016\/j.jep.2024.117975","volume":"327","author":"X Feng","year":"2024","unstructured":"Feng, X. et al. Yinchen Gongying Decoction mitigates CCl(4)-induced chronic liver injury and fibrosis in mice implicated in Inhibition of the FoxO1\/TGF-beta1\/ Smad2\/3 and YAP signaling pathways. J. Ethnopharmacol. 327, 117975 (2024).","journal-title":"J. Ethnopharmacol."},{"key":"97523_CR54","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.gastrohep.2020.09.014","volume":"44","author":"Y He","year":"2021","unstructured":"He, Y. et al. Silencing HIF-1alpha aggravates non-alcoholic fatty liver disease in vitro through inhibiting PPAR-alpha\/ANGPTL4 singling pathway. Gastroenterol. Hepatol. 44, 355\u2013365 (2021).","journal-title":"Gastroenterol. Hepatol."},{"key":"97523_CR55","doi-asserted-by":"publisher","first-page":"e13158","DOI":"10.1111\/cpr.13158","volume":"55","author":"S Yuan","year":"2022","unstructured":"Yuan, S. et al. Sorafenib attenuates liver fibrosis by triggering hepatic stellate cell ferroptosis via HIF-1alpha\/SLC7A11 pathway. Cell. Prolif. 55, e13158 (2022).","journal-title":"Cell. Prolif."},{"key":"97523_CR56","doi-asserted-by":"publisher","first-page":"1868","DOI":"10.1111\/jgh.16272","volume":"38","author":"IA Marcondes-de-Castro","year":"2023","unstructured":"Marcondes-de-Castro, I. A., Reis-Barbosa, P. H., Marinho, T. S., Aguila, M. B. & Mandarim-de-Lacerda, C. A. AMPK\/mTOR pathway significance in healthy liver and non-alcoholic fatty liver disease and its progression. J. Gastroenterol. Hepatol. 38, 1868\u20131876 (2023).","journal-title":"J. Gastroenterol. Hepatol."},{"key":"97523_CR57","doi-asserted-by":"publisher","first-page":"132","DOI":"10.1186\/s10020-023-00721-7","volume":"29","author":"T Guo","year":"2023","unstructured":"Guo, T. et al. Liraglutide attenuates type 2 diabetes mellitus-associated non-alcoholic fatty liver disease by activating AMPK\/ACC signaling and inhibiting ferroptosis. Mol. Med. 29, 132 (2023).","journal-title":"Mol. Med."},{"key":"97523_CR58","doi-asserted-by":"publisher","first-page":"101401","DOI":"10.1016\/j.xcrm.2024.101401","volume":"5","author":"MF Fondevila","year":"2024","unstructured":"Fondevila, M. F. et al. p63 controls metabolic activation of hepatic stellate cells and fibrosis via an HER2-ACC1 pathway. Cell. Rep. Med. 5, 101401 (2024).","journal-title":"Cell. Rep. Med."},{"key":"97523_CR59","doi-asserted-by":"publisher","first-page":"1435051","DOI":"10.3389\/fnut.2024.1435051","volume":"11","author":"C Yang","year":"2024","unstructured":"Yang, C. et al. Effects of dietary amylose\/amylopectin ratio on antioxidant ability and amino metabolism in the liver of weaned piglets undergoing feed transition and challenged with lipopolysaccharide. Front. Nutr. 11, 1435051 (2024).","journal-title":"Front. Nutr."},{"key":"97523_CR60","doi-asserted-by":"crossref","unstructured":"Huang, T. Y. et al. Furanocoumarin Notopterol: Inhibition of Hepatocellular Carcinogenesis through Suppression of Cancer Stemness Signaling and Induction of Oxidative Stress-Associated Cell Death. Nutrients 15, (2023).","DOI":"10.3390\/nu15112447"},{"key":"97523_CR61","doi-asserted-by":"publisher","first-page":"4813","DOI":"10.21873\/anticanres.17307","volume":"44","author":"SU Moon","year":"2024","unstructured":"Moon, S. U., Shah, M., Thao, T. T. & Woo, H. G. Long Non-coding RNA TPRG1-AS1 interacts with CLTC in liver cancer cells. Anticancer Res. 44, 4813\u20134824 (2024).","journal-title":"Anticancer Res."},{"key":"97523_CR62","doi-asserted-by":"publisher","first-page":"93","DOI":"10.2147\/JEP.S504511","volume":"17","author":"TA Mohammed","year":"2025","unstructured":"Mohammed, T. A. & Zalzala, M. H. Hepatoprotective effects of cilnidipine in cholestatic liver disease: role of FXR and NRF2 signalling. J. Exp. Pharmacol. 17, 93\u2013105 (2025).","journal-title":"J. Exp. Pharmacol."},{"key":"97523_CR63","doi-asserted-by":"publisher","first-page":"108023","DOI":"10.1016\/j.bioorg.2024.108023","volume":"154","author":"MS Abusaif","year":"2025","unstructured":"Abusaif, M. S. et al. Exploring a novel thiazole derivatives hybrid with fluorinated-indenoquinoxaline as dual inhibitors targeting VEGFR2\/AKT and apoptosis inducers against hepatocellular carcinoma with Docking simulation. Bioorg. Chem. 154, 108023 (2025).","journal-title":"Bioorg. Chem."},{"key":"97523_CR64","doi-asserted-by":"crossref","unstructured":"Wu, M. T. et al. MTHFR knockdown assists cell defense against folate depletion induced chromosome segregation and uracil misincorporation in DNA. Int. J. Mol. Sci. 22, 9392 (2021).","DOI":"10.3390\/ijms22179392"},{"key":"97523_CR65","doi-asserted-by":"publisher","first-page":"6331","DOI":"10.2147\/DDDT.S496195","volume":"18","author":"X Chen","year":"2024","unstructured":"Chen, X., Hu, K., Zhang, Y., He, S. M. & Wang, D. D. CXCR2 activated JAK3\/STAT3 signaling pathway exacerbating hepatotoxicity associated with tacrolimus. Drug Des. Devel Ther. 18, 6331\u20136344 (2024).","journal-title":"Drug Des. Devel Ther."},{"key":"97523_CR66","doi-asserted-by":"publisher","first-page":"e0318336","DOI":"10.1371\/journal.pone.0318336","volume":"20","author":"L Yu","year":"2025","unstructured":"Yu, L., Yu, P., Cao, Y. & Cao, W. Mechanism of radix bupleuri and hedysarum multijugum Maxim drug pairs on liver fibrosis based on network pharmacology, bioinformatics and molecular dynamics simulation. PLoS One. 20, e0318336 (2025).","journal-title":"PLoS One"},{"key":"97523_CR67","doi-asserted-by":"publisher","first-page":"115230","DOI":"10.1016\/j.fct.2024.115230","volume":"196","author":"M Bishnolia","year":"2025","unstructured":"Bishnolia, M. et al. Methyl donor ameliorates CCl(4)-induced liver fibrosis by inhibiting inflammation, and fibrosis through the downregulation of EGFR and DNMT-1 expression. Food Chem. Toxicol. 196, 115230 (2025).","journal-title":"Food Chem. Toxicol."},{"key":"97523_CR68","doi-asserted-by":"publisher","first-page":"116278","DOI":"10.1016\/j.ecoenv.2024.116278","volume":"275","author":"B Ge","year":"2024","unstructured":"Ge, B. et al. Integrated network toxicology, molecular docking, and in vivo experiments to elucidate molecular mechanism of aflatoxin B1 hepatotoxicity. Ecotoxicol. Environ. Saf. 275, 116278 (2024).","journal-title":"Ecotoxicol. Environ. Saf."},{"key":"97523_CR69","doi-asserted-by":"crossref","unstructured":"Chen, Q. et al. Study on the mechanism of Mesaconitine-Induced hepatotoxicity in rats based on metabonomics and toxicology network. Toxins (Basel) 14, 486 (2022).","DOI":"10.3390\/toxins14070486"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97523-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97523-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97523-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,21]],"date-time":"2025-04-21T10:02:35Z","timestamp":1745229755000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-025-97523-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,21]]},"references-count":69,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["97523"],"URL":"https:\/\/doi.org\/10.1038\/s41598-025-97523-0","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,21]]},"assertion":[{"value":"24 December 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 April 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"13712"}}